Stock Report

All about this stock under one free report Last Updated: 01-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Amicus Therapeutics (FOLD) Key Ratios

Stock Card factsheet share-fund-plan-icon

$14.49

$0.00 (0.00%)

As on 27-Apr-2026 09:30EDT

Market cap

info icon

$4,550 Mln

Revenue (TTM)

info icon

$634 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

16.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 9.55 23.72 20.05 24.43 19.44
EBIT -68.31 -26.75 122.39 30.57 16.91
Net Profit -90.23 -88.53 51.68 23.61 13.72
EPS -90.36 -89.09 51.94 23.69 13.90
Book Value -- -- 34.44 25.85 -4.41
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -4.59-28.897.313.95-25.03
Net Margin info ---76.51------
Return on equity info -50.10-68.92-11.58-31.68-107.04
Return on Capital info -12.87-21.66-3.89-9.03-25.68
Return on Assets info -10.16-17.50-3.13-7.18-20.18
Debt to Equity (x) info ----1.762.292.78

Profitability

View Detailed Peer Comparison

ROCE

-3.89

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
-3.89
-9.03
-25.68
-35.77
-33.95
Peer Median
--
--
--
--
--
ROE

-11.58

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
-11.58
-31.68
-107.04
-109.93
-84.37
Peer Median
--
--
--
--
--
ROA

-3.13

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
-3.13
-7.18
-20.18
-29.04
-27.96
Peer Median
--
--
--
--
--
EBIT Margin

7.31

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
7.31
3.95
-25.03
-62.24
-68.44
Peer Median
--
--
--
--
--
Net Margin

-4.27

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
-4.27
-10.62
-37.96
-70.32
-82.70
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

0.20

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
0.20
0.32
0.21
0.08
0.17
Peer Median
--
--
--
--
--
EBIT Growth

122.39

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
122.39
120.85
51.22
1.99
16.97
Peer Median
--
--
--
--
--
Net Profit Growth

51.68

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
51.68
62.99
35.92
5.55
9.53
Peer Median
--
--
--
--
--
EPS Growth

0.54

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
0.54
0.64
0.39
0.06
0.15
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

1.76

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
1.76
2.29
2.78
3.67
1.43
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.03

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
0.03
0.04
0.05
0.07
0.02
Peer Median
--
--
--
--
--
Current Ratio

2.84

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
2.84
3.39
2.88
3.05
4.09
Peer Median
--
--
--
--
--
Quick Ratio

1.88

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
1.88
2.60
2.52
2.88
3.90
Peer Median
--
--
--
--
--
Interest Coverage

1.00

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
1.00
0.42
-1.99
-5.52
-6.44
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

18.18

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
18.18
19.14
21.94
20.11
17.24
Peer Median
--
--
--
--
--
Asset Turnover

0.73

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
0.73
0.68
0.53
0.40
0.34
Peer Median
--
--
--
--
--
Receivable days

62.32

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
62.32
65.24
70.35
65.94
59.53
Peer Median
--
--
--
--
--
Inventory Days

789.67

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
789.67
615.65
408.60
239.57
245.72
Peer Median
--
--
--
--
--
Payable days

94.45

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
94.45
96.82
149.39
174.71
204.40
Peer Median
--
--
--
--
--
Cash Conversion Cycle

757.53

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
757.53
584.08
329.56
130.79
100.85
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-165.12

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
-165.12
-50.21
-27.48
-14.51
-12.86
Peer Median
--
--
--
--
--
Price / Book Value

16.32

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
16.32
14.52
26.01
27.89
10.48
Peer Median
--
--
--
--
--
EV/EBITDA

86.72

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Amicus Therapeutics (FOLD)
86.72
102.44
-46.97
-17.99
-15.67
Peer Median
--
--
--
--
--
loading...
loading...